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Psychosis is a severe disabling condition and associated with increased morbidity as well as premature 
mortality.(McGrath et al., 2008) Though little is known about the etiology of psychosis, it is a partly 
preventable mental illness and life-style factors have been implicated in its development. 
Cardiorespiratory fitness (CRF), as measured by maximal oxygen uptake (VO2max), is considered the gold 
standard for assessing aerobic capacity and is an index of cardiac and respiratory functioning.(Noonan 
and Dean, 2000) Cardiorespiratory fitness is well known to be strongly inversely and independently 
associated with the risk of cardiovascular disease (CVD)(Kodama et al., 2009) and all-cause 
mortality.(Kodama et al., 2009) Individuals with psychotic disorders have been shown to have lower 
CRF.(Vancampfort et al., 2015) Accumulating evidence suggests that people with psychotic disorders 
such as schizophrenia are at high cardiovascular risk and CVDs are the major contributing factors for the 
increased mortality rates in these individuals.(Olfson et al., 2015) Given that CRF is a major modifiable 
risk factor for CVD in the general population, we hypothesized that CRF could be related to the 
development of psychosis. In this context, we aimed to assess the association of CRF with future risk of 
psychosis, using a population-based cohort of 2,212 Caucasian men, who were apparently free from any 
mental illness during baseline assessments.  
The current analysis employed the Finnish Kuopio Ischemic Heart Disease (KIHD) risk factor study 
which comprised a representative sample of middle-aged men aged 42-61 years recruited from eastern 
Finland. Details of recruitment methods, ethical permissions, and assessment of risk markers have been 
described in a previous report.(Kunutsor et al., 2017) Maximal oxygen uptake was used as a measure of 
CRF, which was assessed using respiratory gas exchange analyzers during cycle ergometer exercise 
testing. Repeat measurements were performed several years apart in a random subset of participants. A 
detailed description of the measurement of VO2max has been reported elsewhere.(Kunutsor et al., 2017) 
Data on hospitalizations due to psychotic disorders were ascertained by linkage to the National Hospital 
Discharge Register. The diagnoses of psychotic disorders were made by qualified psychiatrists and details 
have been previously described.(Kunutsor and Laukkanen, 2017) For the current analysis, men on 
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antipsychotic medication at study entry (n=54) were excluded. Hazard ratios (HRs) with 95% confidence 
intervals (CIs) for psychosis were calculated using Cox proportional hazard models. All statistical 
analyses were conducted using Stata version 14 (Stata Corp, College Station, Texas). 
The mean [standard deviation (SD)] age and CRF of participants at baseline were 53 (5) years and 
30.4 (8.0) ml/kg/min respectively. During a median (interquartile range) follow-up of 25.2 (18.2-27.1) 
years, 215 hospital diagnosed psychotic disorders were recorded (annual rate 4.43/1000 person-years at 
risk; 95% CI 3.87 to 5.06). Overall, the age-adjusted regression dilution ratio of CRF was 0.58 (95% CI: 
0.52 to 0.63), which suggests that the association of CRF with risk of psychosis using one-off or baseline 
measurements of CRF could under-estimate the risk by [(1/0.58)-1]*100 = 72%. Cardiorespiratory fitness 
was approximately linearly and inversely associated with risk of psychosis after adjustment for 
established risk factors (age, smoking status, history of diabetes, prevalent history of coronary heart 
disease, years of education, total cholesterol, and alcohol consumption). The age-adjusted HR for 
psychosis per 1 SD increase in CRF was 0.79 (95% CI: 0.67 to 0.92), which persisted on further 
adjustment for established risk factors 0.80 (95% CI: 0.68 to 0.95). The HR remained consistent on 
additional adjustment for total energy intake, socioeconomic status, physical activity, and C-reactive 
protein 0.82 (95% CI: 0.69 to 0.98). Comparing the top quartile versus bottom quartile of CRF levels, the 
corresponding adjusted HRs were 0.55 (95% CI: 0.37 to 0.82), 0.59 (95% CI: 0.39 to 0.90), and 0.64 
(95% CI: 0.42 to 0.98) respectively. The associations were stronger after correction for within-person 
variability in CRF levels (Table).  
In this first prospective evaluation of the association between CRF and risk of psychosis, our results 
show an inverse independent and approximately dose-response relationship between CRF and future risk 
of psychosis in middle-aged Caucasian men who had no pre-existing mental illness at study entry. 
Chronic inflammatory processes as well as oxidative stress have been implicated in the pathogenesis of 
psychotic disorders. (Feigenson et al., 2014; Owe-Larsson et al., 2011) Cardiorespiratory fitness, which is 
influenced by both genetic and environmental factors, is an index of the level of physical activity. Since 
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physical activity exerts its protective effects on adverse vascular outcomes via anti-inflammatory and 
anti-oxidant processes; (Ford, 2002) it is reasonable to postulate that these same pathways may partly 
underlie the protective relationship observed between CRF and future psychosis risk. It is well established 
that physical activity has important health benefits and confers long-term protection on the cardiovascular 
system and mortality.(Erikssen et al., 1998) Physical activity has also been shown to improve mental 
health and reduce care needs in people with psychotic disorders.(Scheewe et al., 2013) Taken together, 
the overall findings suggest that promoting good CRF levels via regular physical activity may protect 
against the development of mental illness such as psychotic disorders. Further research is needed to 
replicate this relationship and if CRF can be used to improve risk stratification of individuals at high risk 
of psychotic disorders. 
The strengths of the current analysis include the use of a large-scale population-based prospective 
cohort of men recruited from the general population who were free from mental illness at baseline, long-
term and complete follow-up of all participants, adjustment for a comprehensive panel of confounders, 
and correction for within-person variability in CRF levels. Our analyses were limited by the following: (i) 
the inability to generalize the findings to both genders, because the initial study sample comprised only 
men; (ii) the possibility of residual confounding, being an observational study, and (iii) the outcome was 
based on all types of psychotic disorders. 
In conclusion, CRF is associated with reduced risk of future psychosis in an approximately graded 
dose-response pattern in middle-aged Caucasian men. The prognostic value of CRF for future psychosis 
risk deserves further evaluation. 
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Table. Association of cardiorespiratory fitness and risk of psychosis 
CRF 
(ml/kg/min) 
Events/ 
Total 
Model 1  Model 2  Model 3  
  HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value 
Baseline CRF 
Per 1 SD increase 215 / 2,221 0.79 (0.67 to 0.92) 0.003 0.80 (0.68 to 0.95) 0.009 0.82 (0.69 to 0.98) 0.027 
Q1 (6.36-25.25) 72 / 556 ref  ref  ref  
Q2 (25.27-30.15) 51 / 555 0.62 (0.43 to 0.88) 0.008 0.62 (0.43 to 0.89) 0.010 0.63 (0.44 to 0.92) 0.016 
Q3 (30.15-35.28) 51 / 555 0.66 (0.46 to 0.96) 0.028 0.66 (0.45 to 0.96) 0.030 0.68 (0.47 to 1.01) 0.053 
Q4 (35.28-65.40) 41 / 555 0.55 (0.37 to 0.82) 0.004 0.59 (0.39 to 0.90) 0.013 0.64 (0.42 to 0.98) 0.039 
Usual CRF* 
Per 1 SD increase 215 / 2,221 0.66 (0.51 to 0.86) 0.003 0.68 (0.51 to 0.91) 0.009 0.72 (0.53 to 0.96) 0.027 
Q1 (6.36-25.25) 72 / 556 ref  ref  ref  
Q2 (25.27-30.15) 51 / 555 0.43 (0.23 to 0.81) 0.008 0.43 (0.23 to 0.82) 0.010 0.46 (0.24 to 0.86) 0.016 
Q3 (30.15-35.28) 51 / 555 0.49 (0.26 to 0.93) 0.028 0.49 (0.25 to 0.93) 0.030 0.52 (0.27 to 1.01) 0.053 
Q4 (35.28-65.40) 41 / 555 0.36 (0.18 to 0.72) 0.004 0.41 (0.20 to 0.83) 0.013 0.46 (0.22 to 0.96) 0.039 
 
CI, confidence interval; CRF, cardiorespiratory fitness; HR, hazard ratio; ref, reference; Q, quartile; SD, standard deviation;  
*, indicates correction for within-person variability in values of CRF, that is, the extent to which an individual’s CRF 
measurements vary around a long-term average value (“usual CRF values”) 
Model 1: Adjusted for age  
Model 2: Model 1 plus smoking status, history of diabetes, prevalent coronary heart disease, years of education, total cholesterol, 
and alcohol consumption 
Model 3: Model 2 plus total energy intake, socioeconomic status, physical activity, and C-reactive protein 
 
 
 
 
 
